#PowerSafely

An EAP-Duracell Partnership

Awareness

Response

Prevention

#PowerSafely

An EAP-Duracell Partnership

The European Academy of Paediatrics (EAP) and the battery manufacturer Duracell have launched a joint campaign to drive awareness of the dangers of swallowing coin batteries, in particular related to Lithium Coin batteries, for children. To help keep families safe, they are joining forces to “power safely”. Together, they are educating parents and caregivers about the dangers of swallowing lithium coin batteries – and how to prevent it.

Brussels/Geneva, 12 November 2024 – The European Academy of Paediatrics (EAP) and Duracell are extending their strategic partnership to continue their joint #PowerSafely campaign for a further three-year period, from 2025 onwards.

The joint objective of EAP and Duracell remains a significant reduction of the risk of Lithium Coin cell ingestion, and the number of actual cases. To that end, the partners continue to drive the awareness about prevention among parents and health care professionals. They will also address paediatricians, particularly EAP members, and other practitioners to improve their knowledge about detection, treatment and cure.

EAP and Duracell will also reinforce their public advocacy across Europe for the collection of reliable statistical data on battery ingestion by children hospital admissions etc. They are calling upon Eurostat and all national statistical offices to introduce the collection and publication of structured data related to battery ingestion incidents, particularly among young children.

“We are extremely happy to continue collaborating with Duracell to help minimise the risks of battery ingestions,” says Berthold Koletzko, President of the European Academy of Paediatrics. “As part of our joint #PowerSafely campaign, we are launching a series of infographics called ‘Protect Your Children’ which we share in 15 languages. Our members are invited to hang up the information in their waiting rooms i.e., a prime location to reach parents and caregivers.” “We also developed a master presentation for health care professionals to advise on detection, first aid and further treatment of battery ingestion.”

Javier Hernandez Reta, President Duracell Europe & Africa, adds, “We are proud about partnering with the leading paediatric association in Europe. While EAP’s expertise about child health and paediatric care is outstanding, we are contributing to the partnership through our unique knowledge about battery innovation for the benefit of child safety and our understanding of consumer attitudes.”

“A key criterion for our success will be the collection of reliable data about the ingestion of Lithium Coin cells. Such multi-year statistics will form a solid basis to understand the full magnitude of the issue, as well as the effectiveness of innovative solutions.”

#PowerSafely Campaign

We invite you to use the materials below as a part of the EAP-Duracell #PowerSafely campaign.

#PowerSafely Social Media Campaign

We have created #PowerSafely banners for dissemination on social media. We encourage use of the hashtag #PowerSafely for better visibility.

Download the banner and logo in your language here

Waiting Room Infographic

We have made an infographic intended for display in waiting rooms and offices. Don’t hesitate to send round to surgeries and clinics in your country.

Download the infographic here

Press Release

Read the EAP Press Release to drive awareness of the dangers of coin battery swallowing, in particular related to Lithium Coin batteries, for children

Read the Presss release here

Presentations & infographics for healthcare professionals and partents offers guidance on the detection, first aid, and treatment of battery ingestion. These are available in multiple languages!

Coming soon:

Azerbaijan, Bosnian, Estonian, Lithuanian, Maltese, Serbian, Slovakian, Slovenian, and more…

FOR PARENTS

FOR MEDICAL PROFESSIONALS

POWERPOINT PRESENTATION

The #Powersafely campaign promotes

Awareness

We have created #PowerSafely banners for dissemination on social media. We encourage use of the hashtag #PowerSafely for better visibility.

Prevention

Preventive measures that can be taken to ensure your kids don’t swallow button batteries.

Response

What to do if your child swallows a button battery.

Core-MD Project

Coordinating Research and Evidence for Medical Devices (CORE-MD)

New ways to test high-risk medical devices.

 

Manufacturers of medical devices need to test their products before being allowed to market them. Specifically, they require clinical data showing their medical device is safe and efficient. In this context, the EU-funded CORE-MD project will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators. The project will propose how new trial designs can contribute and suggest ways to aggregate real-world data from medical device registries.


It will also conduct multidisciplinary workshops to propose a hierarchy of levels of evidence from clinical investigations, as well as educational and training objectives for all stakeholders, to build expertise in regulatory science in Europe. CORE–MD will translate expert scientific and clinical evidence on study designs for evaluating high-risk medical devices into advice for EU regulators, to achieve an appropriate balance between innovation, safety, and effectiveness. A unique collaboration between medical associations, regulatory agencies, notified bodies, academic institutions, patients’ groups, and health technology assessment agencies, will systematically review methodologies for the clinical investigation of high-risk medical devices, recommend how new trial designs can contribute, and advise on methods for aggregating real-world data from medical device registries with experience from clinical practice The consortium is led by the European Society of Cardiology and the European Federation of National Associations of Orthopaedics and Traumatology, and involves all 33 specialist medical associations that are members of the Biomedical Alliance in Europe.

EAP Representative:

ImmuHubs Project​

Innovative Immunisation Hubs (ImmuHubs)​

EAP is a member of the Consortium running the project funded by the European Union’s Health Programme (2014 – 2020)  entitled Innovative Immunisation Hubs.

 

The ImmuHubs Coordinator is Barbara Rath, MD PhD HDR, Co-founder & Chair, The Vienna Vaccine Safety Initiative.

 

The past year has highlighted that specific groups in European society have limited access to vaccines due to socioeconomic, cultural, geographic or health reasons. The Innovative Immunisation Hubs (ImmuHubs) project, which is designed to run for three years, has been set up in response to this. The project’s aims are to: establish partnerships with citizen groups, public health agencies and the public to improve access for specific population groups in eight countries; create innovative immunisation actions to increase vaccine uptake; develop sustainable solutions for vaccine protection. Among the targeted countries are Cyprus, Greece, Finland, Portugal & Poland. Actions taken will be monitored and the project has quantifiable targets such as increasing the uptake of childhood vaccines by 10 percent. 

EAP Representatives:

Overcoming Obstacles to Vaccination

Overcoming Obstacles in Vaccination

EAP is proud to be involved in the “Overcoming Obstacles to Vaccination” project consortium to enhance immunization efforts and contribute  to public health across diverse fronts. 

 

This is a comprehensive three-year initiative funded by the European Health and Digital Executive Agency (HaDEA) on behalf of the European Commission. This project is dedicated to addressing challenges related to seven critical vaccines: COVID-19, Human Papillomavirus (HPV), Influenza, Measles, Mumps, Rubella (MMR), Meningitis, Polio, and Tetanus.

 

The Overcoming Obstacles to Vaccination project is led by Verian in partnership with the European Health Management Association (EHMA), the Foundation for the Promotion of Health and Biomedical Research of Valencia Region (Fisabio)ifok, the European Academy of Paediatrics (EAP), and the European Regional and Local Health Authorities (EUREGHA).

Your Enquiries Are Welcome

We will respond to you by Email